Endomedix, Inc.

Endomedix is a pre-clinical biotechnology firm with particular expertise and experience in specialized polysaccharide chemistry. The Company has developed internally PLEXimine, a unique platform technology that can be used to develop game-changing products in 5 product groups or sectors. PLEXimine can produce dynamic, structured devices that form in situ during procedures. Already protected by a robust patent estate, the Company’s technology is poised to create new chapter in biosurgical techniques and devices. Our first device, PlexiClot™ Absorbable Hemostat is targeted at a large underserved market in brain and spine surgery.